No black box warning on record for Atomoxetine

As of the latest FDA labeling reviewed, Atomoxetine (ATOMOXETINE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Atomoxetine medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Suicidal Ideation – Monitor for suicidality, clinical worsening, and unusual changes in behavior. ( 5.1 ) • Severe Liver Injury – Should be discontinued and not restarted in patients with jaundice or laboratory evidence of liver injury. ( 5.2 ) • Serious Cardiovascular Events – Sudden death, stroke and myocardial infarction have been reported in association with atomox

No black box warning on record for Atomoxetine

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Suicidal Ideation – Monitor for suicidality, clinical worsening, and unusual changes in behavior. ( 5.1 ) • Severe Liver Injury – Should be discontinued and not restarted in patients with jaundice or laboratory evidence of liver injury. ( 5.2 ) • Serious Cardiovascular Events – Sudden death, stroke and myocardial infarction have been reported in association with atomox

Atomoxetine Black Box Warning

No black box warning on record for Atomoxetine

Other warnings & precautions

Atomoxetine Black Box Warning

No black box warning on record for Atomoxetine

Other warnings & precautions